Curcumin also enhances the effects of cisplatin by targeting the CSCs CD166+/EpCAM+ subpopulation in non-small cell lung cancer cell lines (NSCLC) by p21- and cyclin D1-mediated tumor cell inhibition 12. Here, EPCAM is linked to non-small cell lung carcinoma.